European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
👏Raffaella presenting at #EANO2026 today.
The ARGOS post hoc analysis of EORTC-1709-BTG/CCTG CE.8 (MIRAGE) explored the relationship between radiotherapy quality assurance (RTQA), uninvolved-brain dose, survival, and treatment-related toxicity in patients with glioblastoma.
On 22 September, ECRF celebrated 50 years of supporting cancer research at a Gala Dinner in Brussels, with HRH Princess Dina Mired, representatives of the Belgian Royal House, and Ambassadors of Jordan, Belgium and Monaco. Thank you to all our supporters!
#EORTC#ECRF50
👏International academic collaboration delivering answers.
Just presented at #EANO2026, the ROAM/EORTC-1308 phase III trial found that radiotherapy significantly reduces recurrence risk after complete resection of atypical meningioma.
🔗eortc.org/blog/2026/09/25/ro…@EANOassociation
The EORTC 2335-GUCG #BRACE study has reached an important milestone with the inclusion of its first patient.
Congratulations to all study coordinators, investigators and research teams involved, as well as to the first patient participating in the study. 🔗eortc.org/blog/2026/08/03/eo…
One day after marking the 10th anniversary of #WorldCancerResearchDay in Brussels, the message remains clear: progress happens when we work together.
We thank all who contributed to yesterday’s celebration at EORTC HQ and to progress in cancer research worldwide.
“Cancer does not discriminate. We cannot allow scientific progress to become a source of social inequality.”
A powerful message from Her Majesty Queen Letizia of Spain at yesterday's #WorldCancerResearchDay event.
Access to innovation must benefit all patients.
#CancerResearch
La Reina, en el acto internacional del #WorldCancerResearchDay
🗨️ El cáncer no discrimina; no le importa dónde nacemos, dónde vivimos o con qué recursos contamos. No podemos permitir que el progreso científico se convierta en una fuente de desigualdad social.
👏 Congratulations to @sisaqol on a successful pilot in-person training in Zagreb. Thank you to all participants, faculty & organisers who contributed to this inaugural edition. We look forward to its impact on PROs & #HRQoL in cancer #ClinicalTrials.
#SISAQOLtraining#SISAQOL
📸 A look back at the #SISAQOL pilot in-person training in Zagreb!
Thank you to all participants & the faculty, who came together to exchange knowledge and share best practices for the implementation of PROs & #HRQoL in cancer #ClinicalTrials.
See you in 2027!
#SISAQOLtraining
At today’s #WorldCancerResearchDay event, Denis Lacombe, CEO of EORTC:
"World Cancer Research Day reminds us that better cancer care is not always about more treatment, but about the right treatment for the right patient, supported by strong academic cancer research."
📢 Join us live at 15:00 CEST!
Today, cancer research leaders gather in Brussels to mark the 10th Anniversary of #WorldCancerResearchDay.
We are honoured to welcome Her Majesty Queen Letizia of Spain and HRH Princess Dina Mired of Jordan.
🎥Follow live: piped.video/live/35YcRy-KY7s
📚 Delighted to support the @SISAQOL pilot in-person training taking place in Zagreb this week. Looking forward to two days of learning, collaboration and discussion on PROs and HRQoL in cancer clinical trials.
#SISAQOLtraining#QualityofLife#ClinicalTrials
🤝The #SISAQOL pilot in-person training starts today in Zagreb! Bringing together experts & participants to explore the implementation of SISAQOL recommendations for PROs & HRQoL in cancer #ClinicalTrials.
Looking forward to two days of learning & collaboration.
#SISAQOLtraining
New results from the EORTC-1607-GITCG/ABC-09 phase II study provide biomarker insights alongside efficacy data for pembrolizumab plus CisGem in advanced biliary tract cancer.
Thanks to everyone involved in this international research effort.
🔗 eortc.org/publications/
#WorldCancerResearchDay celebrates the impact of cancer research and the collaboration behind progress against cancer.
EORTC is proud to host the World Cancer Research Day International Event on 23 September in Brussels and support this global initiative.
eortc.org/event/world-cancer…
We honour the memory of Prof. Neil Aaronson, founding member of the EORTC Quality of Life Group & a pioneer of quality of life research in oncology.
His legacy continues to shape cancer research & improve the lives of patients worldwide.
Read our tribute: eortc.org/blog/2026/09/07/in…